ISIN | LU0261664030 |
---|---|
Valor Number | 2635488 |
Bloomberg Global ID | JBMSWCI LX |
Fund Name | Migros Bank (Lux) Fonds - SwissStock B |
Fund Provider |
Migros Bank AG, Zurich
www.migrosbank.ch/kontakt |
Fund Provider | Migros Bank AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The fund invests primarily in shares of companies domiciled in Switzerland. Around 60% of assets are invested in large companies, and around 40% in small and medium-size companies. |
Peculiarities | In Liquidation |
Current Price * | 249.13 CHF | 05.03.2025 |
---|---|---|
Previous Price * | 246.24 CHF | 04.03.2025 |
52 Week High * | 250.18 CHF | 03.03.2025 |
52 Week Low * | 219.13 CHF | 16.04.2024 |
NAV * | 249.13 CHF | 05.03.2025 |
Issue Price * | 249.13 CHF | 05.03.2025 |
Redemption Price * | 249.13 CHF | 05.03.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 86,657,235 | |
Unit/Share Assets *** | 63,029,470 | |
Trading Information SIX |
YTD Performance | +9.58% |
30.12.2024 - 05.03.2025
30.12.2024 05.03.2025 |
---|---|---|
1 month | +2.39% |
05.02.2025 - 05.03.2025
05.02.2025 05.03.2025 |
3 months | +7.89% |
05.12.2024 - 05.03.2025
05.12.2024 05.03.2025 |
6 months | +7.51% |
05.09.2024 - 05.03.2025
05.09.2024 05.03.2025 |
1 year | +13.06% |
05.03.2024 - 05.03.2025
05.03.2024 05.03.2025 |
2 years | +17.25% |
06.03.2023 - 05.03.2025
06.03.2023 05.03.2025 |
3 years | +20.27% |
07.03.2022 - 05.03.2025
07.03.2022 05.03.2025 |
5 years | +36.94% |
05.03.2020 - 05.03.2025
05.03.2020 05.03.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 7.85% | |
---|---|---|
UBS Group AG | 6.86% | |
Nestle SA | 5.98% | |
Novartis AG Registered Shares | 5.20% | |
Compagnie Financiere Richemont SA Class A | 4.34% | |
Lonza Group Ltd | 3.53% | |
Alcon Inc | 3.46% | |
Zurich Insurance Group AG | 3.22% | |
Swiss Re AG | 3.18% | |
Sika AG | 3.03% | |
Last data update | 31.01.2025 |
TER | 1.35% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 28.02.2025 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |